[Gene therapy for peripheral arterial diseases in diabetes mellitus]

Nihon Rinsho. 2002 Oct:60 Suppl 10:449-56.
[Article in Japanese]
No abstract available

Publication types

  • Review

MeSH terms

  • Animals
  • Arterial Occlusive Diseases / etiology
  • Arterial Occlusive Diseases / therapy*
  • Chronic Disease
  • Diabetes Complications
  • Endothelial Growth Factors / administration & dosage
  • Endothelial Growth Factors / genetics
  • Fibroblast Growth Factor 2 / administration & dosage
  • Fibroblast Growth Factor 2 / genetics
  • Gene Transfer Techniques
  • Genetic Therapy*
  • Hepatocyte Growth Factor / administration & dosage
  • Hepatocyte Growth Factor / genetics
  • Humans
  • Intercellular Signaling Peptides and Proteins / administration & dosage
  • Intercellular Signaling Peptides and Proteins / genetics
  • Lymphokines / administration & dosage
  • Lymphokines / genetics
  • Myocardial Ischemia / etiology
  • Myocardial Ischemia / therapy*
  • Neovascularization, Physiologic / genetics
  • Vascular Endothelial Growth Factor A
  • Vascular Endothelial Growth Factors

Substances

  • Endothelial Growth Factors
  • Intercellular Signaling Peptides and Proteins
  • Lymphokines
  • Vascular Endothelial Growth Factor A
  • Vascular Endothelial Growth Factors
  • Fibroblast Growth Factor 2
  • Hepatocyte Growth Factor